{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:14:24Z","timestamp":1786947264933,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jpba.2024.115994","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T12:06:35Z","timestamp":1705925195000},"page":"115994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS"],"prefix":"10.1016","volume":"241","author":[{"given":"Marta","family":"Massano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melani","family":"Nu\u00f1ez-Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Papaseit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Hladun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"P\u00e9rez-Ma\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Marchei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Alladio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Gerace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magi","family":"Farr\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.115994_bib1","unstructured":"World Drug Report 2023, United Nations: Office on Drugs and Crime. www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html."},{"key":"10.1016\/j.jpba.2024.115994_bib2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, European drug report 2023. in European drug report. https:\/\/data.europa.eu\/doi\/10.2810\/161905."},{"key":"10.1016\/j.jpba.2024.115994_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320967197","article-title":"New psychoactive substances: a review and updates","volume":"vol. 10","author":"Shafi","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jpba.2024.115994_bib4","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, New psychoactive substances: 25 years of early warning and response in Europe: an update from the EU Early Warning System. https:\/\/data.europa.eu\/doi\/10.2810\/396103."},{"key":"10.1016\/j.jpba.2024.115994_bib5","series-title":"Novel Psychoactive Substances (Second Edition)","first-page":"333","article-title":"Chapter13 - Synthetic cathinones","author":"Layne","year":"2022"},{"key":"10.1016\/j.jpba.2024.115994_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00213-018-5066-6","article-title":"Synthetic cathinone adulteration of illegal drugs","volume":"vol. 236","author":"Oliver","year":"2019","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.jpba.2024.115994_bib7","unstructured":"\"New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? - Gin\u00e9 - 2014 - Drug Testing and Analysis https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/dta.1610."},{"issue":"fasc. 1","key":"10.1016\/j.jpba.2024.115994_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11419-017-0385-6","article-title":"The newest cathinone derivatives as designer drugs: an analytical and toxicological review","volume":"vol. 36","author":"Majchrzak","year":"2018","journal-title":"Forensic Toxicol."},{"issue":"fasc. 1","key":"10.1016\/j.jpba.2024.115994_bib9","first-page":"268","article-title":"Synthetic cathinones related fatalities: an update","volume":"vol. 22","author":"Zaami","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jpba.2024.115994_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.forsciint.2019.02.021","article-title":"Death cases involving certain new psychoactive substances: A review of the literature","volume":"vol. 298","author":"Kraemer","year":"2019","journal-title":"Forensic Sci. Int."},{"issue":"fasc. 5","key":"10.1016\/j.jpba.2024.115994_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jat\/bku021","article-title":"Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine","volume":"vol. 38","author":"Uralets","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.115994_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122340","article-title":"Metabolism of N-ethylhexedrone and buphedrone: An in vivo study in mice using HPLC-MS\/MS","volume":"vol. 1159","author":"Carrola","year":"2020","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2024.115994_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1145140","article-title":"Metabolic stability and metabolite profiling of emerging synthetic cathinones","volume":"vol. 14","author":"Lopes","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"fasc. 1","key":"10.1016\/j.jpba.2024.115994_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/adt.2007.103","article-title":"An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion","volume":"vol. 6","author":"McNaney","year":"2008","journal-title":"ASSAY Drug Dev. Technol."},{"issue":"fasc. 2","key":"10.1016\/j.jpba.2024.115994_bib15","article-title":"Acute pharmacological effects of oral and intranasal mephedrone: an observational study in humans","volume":"vol. 14","author":"Papaseit","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpba.2024.115994_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.705643","article-title":"Acute pharmacological effects and oral fluid concentrations of the synthetic cannabinoids JWH-122 and JWH-210 in humans after self-administration: an observational study","volume":"vol. 12","author":"Mart\u00ednez","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2024.115994_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1143835","article-title":"Age-related modifications in CYP-dependent drug metabolism: role of stress","volume":"vol. 14","author":"Konstandi e E","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"fasc. 5","key":"10.1016\/j.jpba.2024.115994_bib18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2125.2004.02096.x","article-title":"\"Drug metabolism and ageing\"","volume":"vol. 57","author":"Kinirons e M. S. O\u2019Mahony","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2024.115994_bib19","series-title":"ggplot2. in Use R! Cham","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","author":"Wickham","year":"2016"},{"key":"10.1016\/j.jpba.2024.115994_bib20","series-title":"in International Encyclopedia of Statistical Science","first-page":"1658","article-title":"Wilcoxon-Signed-Rank Test","author":"Rey","year":"2011"},{"issue":"fasc. 11","key":"10.1016\/j.jpba.2024.115994_bib21","doi-asserted-by":"crossref","first-page":"9387","DOI":"10.3390\/ijms24119387","article-title":"GC-MS\/MS determination of synthetic cathinones: 4-chloromethcathinone, N-ethyl pentedrone, and N-ethyl hexedrone in oral fluid and sweat of consumers under controlled administration: pilot study","volume":"vol. 24","author":"Nu\u00f1ez-Montero","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"fasc. 1","key":"10.1016\/j.jpba.2024.115994_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.toxlet.2015.10.025","article-title":"Metabolic profile of mephedrone: Identification of nor-mephedrone conjugates with dicarboxylic acids as a new type of xenobiotic phase II metabolites","volume":"vol. 240","author":"Linhart","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jpba.2024.115994_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1145140","article-title":"Metabolic stability and metabolite profiling of emerging synthetic cathinones","volume":"vol. 14","author":"Lopes","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"fasc. 4","key":"10.1016\/j.jpba.2024.115994_bib24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/dta.3214","article-title":"Excretion of mephedrone and its phase I metabolites in urine after a controlled intranasal administration to healthy human volunteers","volume":"vol. 14","author":"Czerwinska","year":"2022","journal-title":"Drug Test. Anal."},{"issue":"fasc. 3","key":"10.1016\/j.jpba.2024.115994_bib25","article-title":"Pharmacokinetics of N-ethylpentylone and its effect on increasing levels of dopamine and serotonin in the nucleus accumbens of conscious rats","volume":"vol. 25","author":"Lin","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.jpba.2024.115994_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122340","article-title":"Metabolism of N-ethylhexedrone and buphedrone: an in vivo study in mice using HPLC-MS\/MS","volume":"vol. 1159","author":"Carrola","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.115994_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2217\/17455057.4.1.51","article-title":"Sex differences in drug addiction: a review of animal and human studies","volume":"vol. 4","author":"Fattore","year":"2008","journal-title":"Women\u2019s. Health Lond. Engl."},{"key":"10.1016\/j.jpba.2024.115994_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.phrs.2017.07.001","article-title":"Sex and gender landscape in pharmacology","volume":"vol. 123","author":"Franconi","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"fasc. 9","key":"10.1016\/j.jpba.2024.115994_bib29","article-title":"Pharmacokinetics and metabolomics of the new psychoactive substance 4-chloroethylcathinone","volume":"vol. 16","author":"Wang","year":"2023","journal-title":"Arab. J. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:38:49Z","timestamp":1760002729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":29,"alternative-id":["S0731708524000347"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.115994","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.115994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115994"}}